Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7789)
All Articles published online
|
Publishing Process of This Article
|
Aug 7, 2014 (publication date) through Nov 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Jeong WJ, Cha PH, Choi KY. Strategies to overcome resistance to epidermal growth factor receptor monoclonal antibody therapy in metastatic colorectal cancer. World J Gastroenterol 2014; 20(29): 9862-9871 [PMID: 25110417 DOI: 10.3748/wjg.v20.i29.9862] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i29/9862.htm |
| Number | Citing Articles |
| 1 |
Giuseppe Aprile, Francesco Giuliani, Stefania Eufemia Lutrino, Caterina Fontanella, Marta Bonotto, Karim Rihawi, Gianpiero Fasola. Maintenance Therapy in Colorectal Cancer: Moving the Artillery Down While Keeping an Eye on the Enemy. Clinical Colorectal Cancer 2016; 15(1): 7 doi: 10.1016/j.clcc.2015.08.002
|
| 2 |
Sandeep Surendra Panikar, Nehla Banu, Jesse Haramati, Susana del Toro-Arreola, Annie Riera Leal, Pedro Salas. Nanobodies as efficient drug-carriers: Progress and trends in chemotherapy. Journal of Controlled Release 2021; 334: 389 doi: 10.1016/j.jconrel.2021.05.004
|
| 3 |
Hila Yousefi, Nima Rezaei. “Post Modern Medicine” would be “calculable and energy-based medicine”: A hypothesis paper. Journal of Medical Hypotheses and Ideas 2015; 9(2): 104 doi: 10.1016/j.jmhi.2015.09.005
|
| 4 |
Sanne CFA Huijberts, Robin MJM van Geel, Rene Bernards, Jos H Beijnen, Neeltje Steeghs.
Encorafenib, Binimetinib and Cetuximab Combined Therapy for Patients with
BRAFV600E
Mutant Metastatic Colorectal Cancer
. Future Oncology 2020; 16(6): 161 doi: 10.2217/fon-2019-0748
|
| 5 |
John Pradeep Veluchamy, Jan Spanholtz, Marleen Tordoir, Victor L. Thijssen, Daniëlle A. M. Heideman, Henk M. W. Verheul, Tanja D. de Gruijl, Hans J. van der Vliet, Fabrizio Mattei. Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer. PLOS ONE 2016; 11(6): e0157830 doi: 10.1371/journal.pone.0157830
|
| 6 |
Tomokazu Ohishi, Mika K. Kaneko, Yukihiro Yoshida, Atsuo Takashima, Yukinari Kato, Manabu Kawada. Current Targeted Therapy for Metastatic Colorectal Cancer. International Journal of Molecular Sciences 2023; 24(2): 1702 doi: 10.3390/ijms24021702
|
| 7 |
Maria Buoncervello, Giulia Romagnoli, Mariachiara Buccarelli, Alessandra Fragale, Elena Toschi, Stefania Parlato, Donatella Lucchetti, Daniele Macchia, Massimo Spada, Irene Canini, Massimo Sanchez, Mario Falchi, Martina Musella, Mauro Biffoni, Filippo Belardelli, Imerio Capone, Alessandro Sgambato, Lucia Ricci Vitiani, Lucia Gabriele. IFN-α potentiates the direct and immune-mediated antitumor effects of epigenetic drugs on both metastatic and stem cells of colorectal cancer. Oncotarget 2016; 7(18): 26361 doi: 10.18632/oncotarget.8379
|
| 8 |
Suping He, Yanxia Wang, Jianhong Qi, Huan Chen, Wei Zhou. Co-delivery liposomes of irinotecan hydrochloride and curcumin in the synergistic treatment of colorectal cancer. Journal of Drug Delivery Science and Technology 2024; 98: 105848 doi: 10.1016/j.jddst.2024.105848
|
| 9 |
Minhu Cui, Mingji Jin, Mingfeng Han, Yingda Zang, Chuangjun Li, Dongming Zhang, Wei Huang, Zhonggao Gao, Xuezhe Yin. <p>Improved Antitumor Outcomes for Colon Cancer Using Nanomicelles Loaded with the Novel Antitumor Agent LA67</p>. International Journal of Nanomedicine 2020; : 3563 doi: 10.2147/IJN.S241577
|
| 10 |
Tomokazu Ohishi, Yukinari Kato, Mika K. Kaneko, Shun-ichi Ohba, Hiroyuki Inoue, Akiko Harakawa, Manabu Kawada. Anti-Metastatic Activity of an Anti-EGFR Monoclonal Antibody against Metastatic Colorectal Cancer with KRAS p.G13D Mutation. International Journal of Molecular Sciences 2020; 21(17): 6037 doi: 10.3390/ijms21176037
|
| 11 |
A Harlé, J Salleron, G Perkins, C Pilati, H Blons, P Laurent-Puig, J L Merlin. Expression of pEGFR and pAKT as response-predictive biomarkers for RAS wild-type patients to anti-EGFR monoclonal antibodies in metastatic colorectal cancers. British Journal of Cancer 2015; 113(4): 680 doi: 10.1038/bjc.2015.250
|
| 12 |
Nunzio Antonio Cacciola, Chiara Calabrese, Umberto Malapelle, Gianluca Pellino, Alfonso De Stefano, Romina Sepe, Roberta Sgariglia, Cristina Quintavalle, Antonella Federico, Antonio Bianco, André Uchimura Bastos, Marco Milone, Claudio Bellevicine, Francesco Milone, Chiara Carlomagno, Francesco Selvaggi, Giancarlo Troncone, Alfredo Fusco, Pierlorenzo Pallante. UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients. Molecular Carcinogenesis 2016; 55(5): 793 doi: 10.1002/mc.22322
|
| 13 |
TAO XU, CHANGQING JING, YULONG SHI, RUIZHENG MIAO, LIPAN PENG, SHUAI KONG, YAN MA, LEPING LI. microRNA-20a enhances the epithelial-to-mesenchymal transition of colorectal cancer cells by modulating matrix metalloproteinases. Experimental and Therapeutic Medicine 2015; 10(2): 683 doi: 10.3892/etm.2015.2538
|